Amylyx signs two manufacturing deals to secure avexitide drug substance supplySep 8PartnershipAmylyx Pharmaceuticals, Inc.avexitide
Amylyx prices 14.09 million-share offering at $35.50 after LUCIDITY topline winAug 20FinancingAmylyx Pharmaceuticals, Inc.avexitide
Amylyx prices public offering of 14.09 million shares at $35.50Aug 20PartnershipAmylyx Pharmaceuticals, Inc.avexitide
Amylyx reports positive Phase 3 results for avexitide in post-bariatric hypoglycemiaAug 18Clinical readoutAmylyx Pharmaceuticals, Inc.avexitide
Amylyx completes LUCIDITY dosing period, sets late-August/early-September readoutAug 6Quarterly updateAmylyx Pharmaceuticals, Inc.avexitide
Sign inSign in